Increased liver enzyme levels of, e.g., aspartate aminotransferase and alanine aminotransferase have conventionally been reported as indicators of liver dysfunction, notably in conditions such as non-alcoholic fatty liver disease (NAFLD) [2]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.